Product

LN-145-S1

Aliases

TIL, autologous tumor infiltrating lymphocytes

2 clinical trials

3 indications

Indication

Metastatic Melanoma

Indication

Squamous Cell Carcinoma of the Head and Neck

Indication

Clinical trial

A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 144/LN-145/LN-145-S1) in Patients With Solid Tumors

Status: Recruiting, Estimated PCD: 2029-08-09

Clinical trial

A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145/LN-145-S1) for the Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Status: Completed, Estimated PCD: 2022-08-08